Abattis Bioceuticals Corp. (ATTBF)

[guay]

Abattis Prepares for Growth in Extracts
Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) represents a unique investment opportunity in the cannabis extracts space. With their distribution agreement in place with Raybot, the company has access to cutting-edge technology that enables the scalable production of highly purified cannabinoids at an extremely low cost. These benefits dovetail nicely with the company’s other downstream products and services, discussed in an earlier article.

Investors may want to take a closer look at the stock as the company gears up to scale its cannabis extracts business and create tremendous value in the cannabis industry. The company’s Northern Vine subsidiary plans to provide extraction, testing, analysis, formulation and other services to licensed producers in Canada to develop co-branded and white-label products.
http://www.cannabisfn.com/abattis-prepares-growth-extracts/